Top

Osteoporosis International

Published in:

01-08-2017 | Letter

Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?

Authors: J. H. M. Driessen, L. M. Knapen, P. P. M. M. Geusens, J. P. W. van den Bergh

Published in: Osteoporosis International | Issue 8/2017

Excerpt

Dear Editor, …

Dombrowski S, Kostev K, Jacob L (2017) Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—a retrospective analysis of real-world data. Osteoporos Int. doi:10.1007/s00198-017-4051-y

Mamza J, Marlin C, Wang C, Chokkalingam K, Idris I (2016) DPP-4 inhibitor therapy and bone fractures in people with type 2 diabetes—a systematic review and meta-analysis. Diabetes Res Clin Pract 116:288–298CrossRefPubMed

Mosenzon O, Wei C, Davidson J, Scirica BM, Yanuv I, Rozenberg A et al (2015) Incidence of fractures in patients with type 2 diabetes in the SAVOR-TIMI 53 trial. Diabetes Care 38(11):2142–2150CrossRefPubMed

Driessen JH, van den Bergh JP, van Onzenoort HA, Henry RM, Leufkens HG, de Vries F (2017) Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: a retrospective population-based cohort study. Diabetes Obes Metab 19(3):421–428CrossRefPubMed

Suissa S (2007) Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 16(3):241–249CrossRefPubMed

Title: Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
Authors: J. H. M. Driessen
L. M. Knapen
P. P. M. M. Geusens
J. P. W. van den Bergh
Publication date: 01-08-2017
Publisher: Springer London
Published in: Osteoporosis International / Issue 8/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-017-4120-2

At a glance: The STEP trials

Springer Medicine

Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2017

Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population

Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmö Diet and Cancer Study

Sex-related variations in cortical and trabecular bone of the femoral neck in an elderly Chinese population

Dietary acid load, trabecular bone integrity, and mineral density in an ageing population: the Rotterdam study

Higher milk intake increases fracture risk: confounding or true association?

Spinal radiographs in those with back pain—when are they appropriate to diagnose vertebral fractures?